Related Experiment Video
Updated: Aug 5, 2026

08:43
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
Generalized Multilevel Multisource Functional Regression With an Application to Alzheimer's Disease
Xiuli Du1, Guorong Yi2, Yenan Ren1
1College of Mathematical Sciences, Ministry of Education Key Laboratory of NSLSCS, Nanjing Normal University, Nanjing, China.
Statistics in Medicine
|August 4, 2026
Summary
This study introduces a new method for analyzing complex Alzheimer's disease data. Bayesian estimation significantly improves disease classification compared to two-stage methods.
Area of Science:
- Biostatistics
- Neuroscience
- Data Science
Background:
- Population aging increases Alzheimer's disease (AD) prevalence.
- Longitudinal studies like ADNI generate complex, multilevel, multisource functional data.
- Understanding disease progression requires advanced analytical methods for this data.
Purpose of the Study:
- To propose a novel estimation method for multilevel multisource functional principal components.
- To develop a generalized multilevel multisource functional regression model.
- To compare two-stage estimation with Bayesian estimation for improved AD classification.
Main Methods:
- Applied multilevel functional principal component analysis to univariate data.
- Estimated multisource principal components using relationships between univariate and multisource models.
- Developed a two-stage estimation method for functional regression.
- Incorporated Bayesian estimation based on the two-stage approach.
Main Results:
- Both proposed two-stage and Bayesian estimation methods demonstrated effectiveness in simulations and empirical analyses.
- Bayesian estimation significantly outperformed two-stage methods in classification performance.
- The methods effectively handle multilevel and multisource functional data for disease progression studies.
Conclusions:
- The novel two-stage estimation method provides a robust approach for analyzing complex functional data in AD research.
- Bayesian estimation offers superior classification accuracy, highlighting its potential for clinical applications in Alzheimer's disease.
- These advancements aid in understanding and potentially predicting Alzheimer's disease progression using diverse datasets.
Related Concept Videos
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

